
|Articles|September 13, 2007
Ortho Biotech supports FDA decision on ESA product label changes
FDA: No label changes needed for ESA product
Advertisement
Summary: Ortho Biotech supports an FDA decision not to change ESA
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
3
Pharmacists Want Prescribing Authority With Proper Training, Support
4
What’s Next for Pneumococcal Vaccination? An Expert Weighs In
5






























